Ciprofloxacine AB 250 mg film-coat. tabl.

Country: Belġju

Lingwa: Ingliż

Sors: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ixtrih issa

Ingredjent attiv:

Ciprofloxacin Hydrochloride 294,586 mg - Eq. Ciprofloxacin 250 mg

Disponibbli minn:

Aurobindo SA-NV

Kodiċi ATC:

J01MA02

INN (Isem Internazzjonali):

Ciprofloxacin Hydrochloride

Dożaġġ:

250 mg

Għamla farmaċewtika:

Film-coated tablet

Kompożizzjoni:

Ciprofloxacin Hydrochloride 294.586 mg

Rotta amministrattiva:

Oral use

Żona terapewtika:

Ciprofloxacin

Sommarju tal-prodott:

CTI code: 477253-01 - Pack size: 1 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 477253-02 - Pack size: 8 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 477253-05 - Pack size: 16 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 477253-06 - Pack size: 20 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 477253-03 - Pack size: 10 - Commercialisation status: YES - FMD code: 08716049030138 - CNK code: 3531712 - Delivery mode: Medical prescription; CTI code: 477253-04 - Pack size: 14 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 477253-07 - Pack size: 100 - Commercialisation status: NO - Delivery mode: Medical prescription

L-istatus ta 'awtorizzazzjoni:

Commercialised: Yes

Data ta 'l-awtorizzazzjoni:

2015-09-01

Dokumenti f'lingwi oħra

Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Ġermaniż 01-07-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Franċiż 01-07-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Franċiż 01-07-2022
DHPC DHPC Franċiż 15-06-2023
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Olandiż 01-07-2022
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Olandiż 01-07-2022
DHPC DHPC Olandiż 15-06-2023